Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT00697632
Title Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors MethylGene Inc.
Age Groups: adult
Covered Countries USA | CAN

Additional content available in CKB BOOST